# MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer

> **NCT01566045** · NA · WITHDRAWN · sponsor: **Philips Healthcare**

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Core Needle TRUS Needle biopsy (Transrectal ultrasound)
- **PROCEDURE:** Core Needle MRI/US image fusion guided needle biopsy

## Key facts

- **NCT ID:** NCT01566045
- **Lead sponsor:** Philips Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-05
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566045, "MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01566045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*